The impact of sarcopenia on tolerance of radiation and outcome in patients with head and neck cancer receiving chemoradiation.
CONCLUSION: Sarcopenic patients receiving concurrent chemoradiation are more likely to require radiation treatment breaks and suffer chemotherapy toxicity than their non-sarcopenic counterparts. This may contribute to worse survival outcomes in head and neck cancer, with the exception of p16-positive oropharyngeal cancer.
PMID: 31085391 [PubMed - as supplied by publisher]
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - Category: Radiology Authors: Ganju RG, Morse R, Hoover A, TenNapel M, Lominska CE Tags: Radiother Oncol Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | CT Scan | Head and Neck Cancer | Oropharyngeal Cancer | PET Scan | Radiology | Science | Smokers | Toxicology